Skip to content

Depression research published in 2025

Page 28 of 39: studies 541 to 560 of 761, newest first. Back to the depression overview

Studies

Mindfulness Interventions in Older Adults for Mental Health and Well-Being: A Meta-Analysis.

The journals of gerontology. Series B, Psychological sciences and social sciences March 12, 2025 Paul Verhaeghen, Shelley N. Aikman, Grazia Mirabito 9 citations

Mindfulness interventions are consistently associated with beneficial effects in younger adults. In this meta-analysis, we seek to quantify the effectiveness of mindfulness interventions for the mental health and well-being of older adults. We include 46 studies that implemented a mindfulness intervention (MBSR = 20; MBCT = 9; ad hoc protocol = 17) with older adults (samples with an average age...

Revealing Changes in Linear and Nonlinear Functional Connectivity After Psilocybin and Escitalopram Treatment in Patients with Depression

bioRxiv (Cold Spring Harbor Laboratory) March 10, 2025 Shaun K.l. Quah, Cameron C. Glick, Leor Roseman et al. preprint

Abstract Major Depressive Disorder (MDD) is typically characterized by altered linear functional connectivity (FC) across large-scale brain networks. Yet, it is unclear whether similar alterations are observed when nonlinear FC is examined. This study investigated how antidepressant treatment (i.e., psilocybin and escitalopram) modulates both linear FC and nonlinear FC in individuals with MDD....

DOI: 10.1101/2025.03.05.641592 (opens in new tab) Full text (opens in new tab) Psilocybin Escitalopram Functional connectivity Depression economics +4

Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action

Biological Psychiatry March 8, 2025 Jonathan Repple, Maximilian Bayas, Chiara Möser et al. 8 citations

After decades of limited progress in depression treatment, recent advancements have sparked renewed interest in developing novel antidepressants, particularly rapid-acting antidepressants (RAADs). Despite these promising developments, there remains a significant gap in research on bipolar depression. While several antipsychotics have been investigated for their efficacy in bipolar depression...

DOI: 10.1016/j.biopsych.2025.02.903 (opens in new tab) Mdd #bipolardisorder manic depression Bipolar affective disorder #ketamine ketamine therapy +5

Feasibility of Modified Mindfulness Training Program for Antenatal Depression and Perceived Stress Among Expectant Mothers with Male Child Preference.

Healthcare March 7, 2025 . Badil, Najma Naz, Dildar Muhammad et al. 2 citations

Background/Objectives: Antenatal depression and perceived stress are prevalent mental health challenges faced by pregnant women, and they are associated with male child preference. This study aimed to assess the feasibility of a modified mindfulness training program for reducing antenatal depression and perceived stress levels among expectant mothers with a male child preference at a public...

DOI: 10.3390/healthcare13060584 (opens in new tab) Full text (opens in new tab) Antenatal depression Expectant mothers Male child preference Perceived stress

Risks of using psilocybin in treatment of treatment-resistant depression

Journal of Education, Health and Sport March 7, 2025 Michał Orzechowski, Joanna Orzechowska, Paulina Fijałek et al.

Introduction As depression rates continue to rise globally, the need for more effective and innovative treatments has become increasingly urgent, highlighting the potential impact of psilocybin as a promising therapeutic option. However, to ensure its safe and effective integration into clinical practice, it is essential to establish robust safety parameters for its administration. This paper...

DOI: 10.12775/JEHS.2025.79.58319 (opens in new tab) Full text (opens in new tab) Treatment resistant depression Safety Psychedelic assisted therapy Adverse effects +1

Effect of Esketamine on Depressive Symptoms in Adolescents With Major Depressive Disorder at Imminent Suicide Risk: A Randomized Psychoactive-Controlled Study.

Journal of the American Academy of Child & Adolescent Psychiatry March 7, 2025 Colette Kosik-Gonzalez, Dong-Jing Fu, Li Nancy Chen et al. 14 citations

To evaluate the efficacy, safety, and tolerability of esketamine nasal spray vs psychoactive placebo (oral midazolam) in rapidly reducing depressive symptoms in adolescents with major depressive disorder at imminent risk for suicide. This double-blind, double-dummy, phase 2b study randomized (1:1:1:2) 147 adolescents (12 to <18 years old) to esketamine (28, 56, or 84 mg) or midazolam twice...

Effect of esketamine on reducing postpartum pain and depression.

World Journal of Clinical Cases March 6, 2025 Brandon P Lucke-Wold, Armin Karamian 9 citations

In this editorial, we comment on a recent article by Chen et al, that addressed the effect of intraoperative injection of esketamine on postoperative analgesia and postoperative rehabilitation after cesarean section. Poor management of post-cesarean pain is associated with decreased maternal care for the baby, longer hospitalization, and higher risk of developing postpartum depression....

DOI: 10.12998/wjcc.v13.i7.100422 (opens in new tab) Full text (opens in new tab) Cesarean-section c-section Esketamine-therapy ketamine treatment Postpartum-depression postnatal depression Baby blues +8

Exploring the Effects of a School Mindfulness-Based Intervention in French Primary Public Schools-A Pilot Study.

Pediatric Reports March 5, 2025 Jessica Monsillion, Lucia Romo, Rafika Zebdi

Background/Objectives: School-Mindfulness-Based Interventions (SMBIs) have shown positive effects on children's mental health by enhancing emotional regulation and present-moment awareness. This pilot study explored the effects of an SMBI program on anxiety, depression, mindfulness, emotional awareness, executive functioning, and school well-being among French primary school students (mean age...

Adverse Effects and Safety of Antidepressants and Psychedelics for Depression in Cancer: A Systematic Review of Randomized Controlled Trials

Psychoactives March 4, 2025 Renan Massanobu Maekawa, Lorena T. L. Guerra, José Carlos Bouso et al.

Depression is common among patients suffering from cancer, but is often challenging to diagnose due to the overlap of symptoms with cancer and its treatments. Additionally, treating depression in cancer patients is challenging because of the confusion between the adverse effects of antidepressants, cancer treatments, and cancer symptoms. This study aims to evaluate the safety and adverse...

A brief virtual reality-based mindfulness intervention can improve olfactory perception while reducing depression and anxiety symptoms in university students

Humanities and Social Sciences Communications March 3, 2025 Jingni Ma, Hao-Ke Li, Chuoyan Liang et al.

With universities increasingly offering mindfulness-based interventions to enhance students’ mental health conditions and alleviate the strain on overwhelmed psychological services, this study aimed to investigate the potential effectiveness of a brief VR-based mindfulness intervention for university students with depression and anxiety symptoms. Employing a quasi-experimental design, the...

Effectiveness of pharmacological and non-pharmacological interventions for treatment-resistant depression in older patients: a systematic review and meta-analysis.

BMJ mental health March 3, 2025 Alice Jane Larsen, Giulia Teobaldi, Rosario Isabel Espinoza Jeraldo et al. 10 citations

Depression in older adults is often undertreated. A 2011 systematic review of treatments for treatment-resistant depression (TRD) in older adults identified one placebo-controlled randomised controlled trial (RCT). We aimed to update this review, synthesising evidence for the effectiveness of treatments for TRD in older people. We systematically searched electronic databases (PubMed, Cochrane,...

Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.

The Journal of Clinical Psychiatry March 3, 2025 Guy M. Goodwin, Ania Nowakowska, Merve Atli et al. 14 citations

Background: The largest randomized study of psilocybin to date demonstrated the efficacy of COMP360 25 mg (Compass Pathways' investigational proprietary pharmaceutical-grade synthesized psilocybin formulation) in participants with treatment-resistant depression (COMP 001), compared with 10 mg and 1 mg doses. Here, we report findings from COMP 004, a 52-week observational follow-up of patients...

Depression and Mindfulness: Reclaiming the Past, Present, and Future

Journal of Humanistic Psychology March 1, 2025 Angelos Sofocleous

This article explores the temporal disturbances experienced in depression and the potential effectiveness of mindfulness-based interventions in addressing these disturbances. Drawing upon a Husserlian framework, this article examines the three temporal phases of experience: retention, primal impression, and protention. These phases constitute the temporal fusion that allows us to perceive an...

Impact of UPLIFT, a group telehealth intervention, on symptoms of depression and anxiety in adults with CF.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society March 2025 Michael S Schechter, Andrea Molzhon, Robin S Everhart et al.

Despite high rates of anxiety and depression, research regarding the effect of psychological interventions on people with CF (pwCF) is limited. We evaluated the impact of UPLIFT (Using Practice and Learning to Increase Favorable Thoughts), a group telehealth intervention using mindfulness-based cognitive behavioral therapy (MBCT), on symptoms of anxiety and depression in pwCF. This multicenter...

Trait Mindfulness, Resilience, Self-Efficacy, and Postpartum Depression: A Dominance Analysis and Serial-Multiple Mediation Model

Psychology Research and Behavior Management March 1, 2025 Xiaoxiao Mei, Ranran Mei, Yan Li et al. 4 citations

Background: Postpartum depression affects many women after childbirth, impacting both maternal and child well-being. Psychological traits such as trait mindfulness, resilience, and self-efficacy have been linked to postpartum depression, but their interactions and collective influence are not well understood. Objective: The study aims to examine the associations between trait mindfulness,...

The Impact of Ketamine-Based Versus Non-Ketamine-Based ECT Anesthesia Regimens on the Severity of Patients’ Depression and Occurrence of Adverse Events: A Systematic Review with Meta-Analysis

Annals of Pharmacotherapy March 1, 2025 Dakota Sicignano, Rohan Kantesaria, Matthew Mastropietro et al.

Objective: To compare efficacy and safety outcomes for ketamine anesthesia + electroconvulsive therapy (ECT) versus nonketamine anesthesia + ECT in treatment-resistant depression (TRD) patients. Data Sources: PubMed and Embase were searched from the earliest date through November 27, 2023. Study Selection and Data Extraction: Relevant randomized controlled trials (RCTs) of ketamine + ECT versus...

Alterations in temporal-spatial brain entropy in treatment-resistant depression treated with nitrous oxide: Evidence from resting-state EEG.

Clinical Neurophysiology March 1, 2025 Weizhuang Kong, Zhe Sun, Jing Zhu et al.

Entropy analysis can quantify the dynamic states of the brain and reflect its information processing capacity. Nitrous oxide has shown rapid antidepressant effects in treatment-resistant depression (TRD) patients, but its biomarkers are not yet established. We recruited 44 TRD patients and randomly assigned them to two groups: one received a 1-hour nitrous oxide inhalation treatment, while the...

DOI: 10.1016/j.clinph.2025.01.014 (opens in new tab) Full text (opens in new tab) Multivariate multiscale entropy Nitrous oxide Resting-State EEG Temporal-spatial brain entropy +1

Neural regulation of pain anticipation is associated with mindful behavior change in patients with anxiety or depression: A pilot study.

Psychiatry Research Neuroimaging March 1, 2025 Michael Datko, Jacqueline Lutz, Richa Gawande et al. 1 citation

Behavior change often requires overcoming discomfort or difficult emotions. Emotional dysregulation associated with anxiety or depression may prevent behavior change initiation among people managing chronic illness. Mindfulness training may catalyze chronic disease self-management by reducing experiential avoidance of aversive experiences that act as barriers to change initiation. Using a fMRI...

Effects of Mindfulness Therapy on Breast Cancer Patients with Depression or Anxiety: A Systematic Review and Meta-analysis.

Actas Españolas de Psiquiatría March 1, 2025 Jingjing Yan, Fenhua Wang, Xianghua Yu 3 citations

Breast cancer (BC) is the most common malignant tumor threatening women's health globally, with rising incidence rates and significant psychological impacts, particularly in China, where the prevalence of depressive and anxious mood disorders among BC patients is notably higher than the global average. To evaluate the effect of mindfulness therapy on anxiety and depressive symptoms in breast...

Perspectives in treatment-resistant depression: esketamine and electroconvulsive therapy.

Wiener klinische Wochenschrift March 1, 2025 Pia Baldinger-Melich, Marie Spies, Ina Bozic et al. 5 citations

Modern electroconvulsive therapy (ECT) and the approval of nasal esketamine for clinical use have significantly improved the approach to treatment-resistant depression (TRD), which is defined as non-response to at least two different courses of antidepressants with verified adherence to treatment, adequate dosage, and duration of treatment. The goal of this literature review is to present the...

DOI: 10.1007/s00508-024-02358-w (opens in new tab) Full text (opens in new tab) Spravato Antidepressant treatment Electroconvulsive therapy ect Treatment-resistant depression trd +6